How many studies have been conducted on Diethyldithiocarbamate?

BiohacksAI has indexed 300 PubMed studies on Diethyldithiocarbamate, including 3 randomized controlled trials (RCTs). 10% of studies involve human subjects.

What are the main research areas for Diethyldithiocarbamate?

The primary research domains for Diethyldithiocarbamate are 🫁 Liver & Detox, 🔬 Oncology, 🫘 Kidney. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Diethyldithiocarbamate

A chelating agent that has been used to mobilize toxic metals from the tissues of humans and experimental animals. It is the main metabolite of DISULFIRAM.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 38.3

Research Domains

Diethyldithiocarbamate has been studied across 19 research domains including 🫁 Liver & Detox, 🔬 Oncology, 🫘 Kidney, 🔬 Inflammation, 🧠 Focus & Attention. The primary research focus is 🫁 Liver & Detox with 20% of studies addressing this area.

Loading evidence profile...

This evidence profile for Diethyldithiocarbamate is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.